Manufacturing Cures: Infrastructure Challenges Facing Cell And Gene Therapy Developers

To Ensure Broad Patient Access To Cell And Gene Therapies Stakeholders Must Address Manufacturing Challenges

 
• By Michael Lehmicke
  
regenerative-medicine
The supply chain for managing new cell and gene therapies is incredibly complex • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Intelligence

More from In Vivo